Search

Bright Spots, Bigger Picture Could it be Normal? MS? Vascular? Migraine?

Attendees will leave able to: Distinguish age-appropriate white matter changes from pathology Apply distinguishing imaging features across the big 3 differential Recognize when atypical patterns warrant a broader workup Formulate more specific, more useful imaging interpretations Presenter Evan Calabrese, MD, PhDAssociate Professor of RadiologyAssistant Professor of Biomedical EngineeringDuke Department of RadiologyDuke University School of Medicine …

What Would You Do? Clinical Case Challenges for Optimal MS Care

Release Date: August 5, 2026 Valid for Credit through: August 5, 2027 CE Information This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC), and Catamount Medical Education. This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation. This activity can take up to 1 hour to complete. Target …

The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosis

Release Date: July 17, 2026 Valid for Credit through: July 16, 2027 Program Overview: This CME/CE program will examine the evolving role of high-efficacy anti-CD40 therapeutics in relapsing multiple sclerosis (RMS), with a focus on how emerging treatments may address both acute and chronic neuroinflammation. Expert faculty, Dr. Fred Lublin, will first review evolving concepts …

Review of Biosimilar Therapeutics for Patients with Relapsing Multiple Sclerosis

Release Date: July 1, 2026 Valid for Credit through: June 30, 2027 Program Overview: This CME/CE program will provide an evidence-based review of biosimilar therapeutics for patients with relapsing multiple sclerosis, with a focus on approval standards, clinical evidence, and practical implications for neurologists as well as for the broader healthcare team. The program will …

Update on Clinical Data and Applications for Anti-CD20 Therapeutics to Treat Relapsing Multiple Sclerosis

Release Date: June 25, 2026 Valid for Credit through: June 24, 2027 Program Overview: This CME/CE program will review current clinical data and practical applications for anti-CD20 therapeutics in the treatment of relapsing multiple sclerosis. Expert neuroinflammatory disease faculty, Drs. Fred D. Lublin and Joseph R. Berger, will critically examine the role of B cells …

IJMSC: Exploring Factors and Nonpharmacological Interventions Associated with Respiratory Function in People with Multiple Sclerosis: A Scoping Review

Release Date: June 1, 2026 Valid for Credit through: June 1, 2028 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, social workers, rehabilitation professionals, respiratory therapists, and other health care providers involved in the management …

IJMSC: Self-Management in Youth with Multiple Sclerosis During Transition to Adult Care and Adulthood: A Qualitative Study Using Interpretive Description

Release Date: April 6, 2026 Valid for Credit through: April 6, 2027 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, mental health professionals, social workers, and other health care providers involved in the management of …

The Inaugural June Halper Excellence in MS Nursing Programs

Release Date: March 19, 2026 Valid for Credit through: March 19, 2027 CE Information This activity is jointly provided by the Consortium of Multiple Sclerosis Centers (CMSC), the International Organization of Multiple Sclerosis Nurses (IOMSN), and Catamount Medical Education. This activity is supported by educational grants from Keenova Therapeutics, previously Mallinckrodt Pharmaceuticals, Novartis, and TG …

IJMSC: Exploring the Effects of a 10-day Ocean Sailing Intervention in People With Multiple Sclerosis: The Ocean Project

Release Date: February 23, 2026 Valid for Credit through: February 23, 2028 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, rehabilitation professionals, social workers, and other health care providers involved in the care of people …

IJMSC: “There’s No Magic Pill”: A Multimethods Qualitative Study Exploring Routine Fatigue Care in Multiple Sclerosis

Release Date: December 9, 2025 Valid for Credit through: December 9, 2027 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, rehabilitation professionals, mental health professionals, social workers, and other health care providers involved in the …